Platelet aggregation response to cyclooxygenase inhibition and thromboxane receptor antagonism using impedance aggregometry: A pilot study
Physiological Reports · 2024
DOI: 10.14814/phy2.70002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2024. Verfasst von Auni C Williams und 3 weiteren Autor:innen. Beteiligte Einrichtung: Noll Laboratory, Department of Kinesiology, The Pennsylvania State University, University Park, Pennsylvania, USA. Hauptthemen laut MEDLINE: Platelet Aggregation, Cyclooxygenase Inhibitors, Aspirin, Receptors, Thromboxane. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, HHS | NIH | National Institute on Aging (NIA), HHS | National Institutes of Health (NIH).
Abstract (Originalsprache)
Impedance aggregometry is an alternative to light transmission aggregometry that allows analysis of platelet function in whole blood samples. We hypothesized (1) impedance aggregometry would produce repeatable results, (2) inhibition of cyclooxygenase with aspirin would attenuate aggregation responses to collagen and abolish the aggregation response to arachidonic acid (AA), and (3) thromboxane receptor antagonism (terutroban) would attenuate the aggregation response to AA. Venous blood was obtained from 11 participants three times separated by at least 2 weeks. One sample followed 7‐day‐aspirin intervention (81 mg once daily; ASA), the others no intervention (control). Aggregation was induced using 1 μg/mL collagen ([col 1]), 5 μg/mL collagen ([col 5]), and 50 mM AA via impedance aggregometry to determine total aggregation (AUC) analyzed for intra‐test repeatability, inter‐test repeatability, intervention (ASA or control), and incubation (saline or terutroban). [col 1] showed high intra‐test ( p ≤ 0.03 visit 1 and 2) and inter‐test repeatability ( p < 0.01). [col 5] and AA showed intra‐ ([col 5] p < 0.01 visit 1 and 2; AA p < 0.001 visit 1 and 2) but not inter‐test repeatability ([col 5] p = 0.48; AA p = 0.06). ASA attenuated AUC responses to [col 1] ( p < 0.01), [col 5] ( p = 0.03), and AA ( p < 0.01). Terutroban attenuated AUC in response to AA ( p < 0.01). [col 1] shows sufficient repeatability for longitudinal investigations of platelet function. [col 5] and AA may be used to investigate mechanisms of platelet function and metabolism at a single time point.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Noll Laboratory, Department of Kinesiology, The Pennsylvania State University, University Park, Pennsylvania, USA.
- Center for Healthy Aging, The Pennsylvania State University, University Park, Pennsylvania, USA.
ORCID-Profile: Auni C Williams
Förderung
- NIA NIH HHS
- HHS | NIH | National Institute on Aging (NIA)
- HHS | National Institutes of Health (NIH)
- NHLBI NIH HHS
- National Institute on Aging
- National Institutes of Health
Zitieren
APA
Williams, A. C., Fisher, K. G., Alexander, L. M., & Kenney, W. L. (2024). Platelet aggregation response to cyclooxygenase inhibition and thromboxane receptor antagonism using impedance aggregometry: A pilot study. Physiological Reports. https://doi.org/10.14814/phy2.70002
Vancouver
Williams AC, Fisher KG, Alexander LM, Kenney WL. Platelet aggregation response to cyclooxygenase inhibition and thromboxane receptor antagonism using impedance aggregometry: A pilot study. Physiological Reports. 2024. doi:10.14814/phy2.70002
BibTeX
@article{Williams2024,
author = {Williams, Auni C and Fisher, Kat G and Alexander, Lacy M and Kenney, W Larry},
title = {Platelet aggregation response to cyclooxygenase inhibition and thromboxane receptor antagonism using impedance aggregometry: A pilot study},
journal = {Physiological Reports},
year = {2024},
doi = {10.14814/phy2.70002}
}
EUVIMED